Azo Gantrisin Interactions
There are 124 drugs known to interact with Azo Gantrisin (phenazopyridine / sulfisoxazole), along with 12 disease interactions. Of the total drug interactions, 23 are major, 100 are moderate, and 1 is minor.
- View all 124 medications that may interact with Azo Gantrisin
- View Azo Gantrisin disease interactions (12)
Most frequently checked interactions
View interaction reports for Azo Gantrisin (phenazopyridine / sulfisoxazole) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen / pseudoephedrine
- Advil Migraine (ibuprofen)
- Aleve (naproxen)
- Alka-Seltzer Plus Cold (acetaminophen / chlorpheniramine / phenylephrine)
- Alka-Seltzer Plus-D Multi-Symptom Sinus & Cold Liquid Gels (acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine)
- amoxicillin
- Ativan (lorazepam)
- Banzel (rufinamide)
- BuSpar (buspirone)
- Celexa (citalopram)
- Culturelle Digestive Health (lactobacillus rhamnosus gg)
- Delsym 12 Hour Cough Relief (dextromethorphan)
- dexamethasone otic
- diclofenac
- Dramamine Less Drowsy (meclizine)
- elderberry
- Flonase (fluticasone nasal)
- guaifenesin
- Keflex (cephalexin)
- Keppra XR (levetiracetam)
- Maalox (aluminum hydroxide / magnesium hydroxide / simethicone)
- Medrol Dosepak (methylprednisolone)
- meloxicam
- Mucinex (guaifenesin)
- Orajel (benzocaine topical)
- oxycodone
- Percocet (acetaminophen / oxycodone)
- Rybelsus (semaglutide)
- semaglutide
Azo Gantrisin disease interactions
There are 12 disease interactions with Azo Gantrisin (phenazopyridine / sulfisoxazole) which include:
- colitis
- G-6-PD deficiency
- hepatitis
- renal dysfunction
- hematologic toxicity
- hypersensitivity reactions
- liver disease
- porphyria
- renal dysfunction
- crystalluria
- hemodialysis
- urinary obstruction
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.